Association of Hemophagocytic Lymphohistiocytosis and Programmed Death 1 Checkpoint Inhibitors

Letter/Communication

Open access

Behnam Laderian, Kelly Koehn, Carol Holman, Laurel Lyckholm and Muhammad Furqan

Journal of thoracic oncology, Vol.14(4), pp.e77-e78

04/2019

DOI: 10.1016/j.jtho.2018.11.035

PMID: 30922584

Files and links (1)

url

https://doi.org/10.1016/j.jtho.2018.11.035View

Published (Version of record) Open Access

Humans

Lymphohistiocytosis, Hemophagocytic - chemically induced

Lymphohistiocytosis, Hemophagocytic - pathology

Male

Middle Aged

Programmed Cell Death 1 Receptor - antagonists & inhibitors

Title: Subtitle: Association of Hemophagocytic Lymphohistiocytosis and Programmed Death 1 Checkpoint Inhibitors
Creators: Behnam Laderian - University of Iowa Hospitals and Clinics
Kelly Koehn - University of Iowa Hospitals and Clinics
Carol Holman - University of Iowa Hospitals and Clinics
Laurel Lyckholm - University of Iowa Hospitals and Clinics
Muhammad Furqan - University of Iowa Hospitals and Clinics
Resource Type: Letter/Communication
Publication Details: Journal of thoracic oncology, Vol.14(4), pp.e77-e78
DOI: 10.1016/j.jtho.2018.11.035
PMID: 30922584
ISSN: 1556-0864
eISSN: 1556-1380
Grant note: P30 CA086862 / NCI NIH HHS
Language: English
Date published: 04/2019
Academic Unit: Hematology, Oncology, and Blood & Marrow Transplantation; Pathology; Internal Medicine
Record Identifier: 9984186393402771

23 Record Views